| Company/Division name | Johnson & Johnson |
| Parent company | Pending tariffs--Johnson & Johnson |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 500 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2029 |
| Capital investment ($): | 55 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption, Tariffs |
| What domestic positive factors made reshoring more attractive? | Manufacturing/engineering joint innovation (R&D), Proximity to customers/market |
